Studies on Cannabis sativa and Cannabinoids

Dear Colleagues, 

In recent years, the worldwide hype of cannabis and cannabis-related products is observable. This cannabis hype on the one hand entailed broad cannabis-related research since many research teams all over the world stepped into this hot topic. Today, many different varieties are already sequenced and transcriptomic data are available. Together with metabolic studies, the biosynthetic routes and the genetics get more and more understood. What is still missing are well designed studies to elucidate the medicinal impact of single cannabinoids. So far, only a limited number of serious studies are available. To ensure a long-term success of cannabis in medicine, much more information is needed. On the other hand, there are some reasons one could be worried, since many trends, provoked by the global money glut, are alarming, such as the efforts and ideas to have cannabinoid and especially THC-containing soft drinks or even alcoholic drinks. This will inevitably lead to a new discussion regarding the legalization of cannabis as recreational drug. The delayed effect of cannabinoids after oral consumption, especially in combination with alcohol, will lead to many overdoses, not to mention the enormous risks of consuming cannabinoids, particularly during early adolescence. It is therefore of enormous importance that scientists from all over the world find answers and exploit the potential of cannabis for human health and not let this unique opportunity pass by. 

In this context, the aim of this Special Issue is to bring together new trends, developments, and especially research papers, in order to get closer to the goal of using cannabis for the benefit of human health.

Dr. Felix Stehle
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Plants is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.